|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0185117,
umls-concept:C0205183,
umls-concept:C0205189,
umls-concept:C0205282,
umls-concept:C0205473,
umls-concept:C0221908,
umls-concept:C0919267,
umls-concept:C0936012,
umls-concept:C1335205,
umls-concept:C1441616,
umls-concept:C2911684
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-11-19
|
|
pubmed:abstractText |
To evaluate (a) the expression of CD31 in benign, borderline, and maligant ovarian tumors; (b) the correlation between CD31 expression and the clinicopathological parameters; and (c) the diagnostic interest of serological soluble CD31 (sCD31) in patients with ovarian tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 1998 Academic Press.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
122-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9784332-Antigens, CD31,
pubmed-meshheading:9784332-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9784332-Female,
pubmed-meshheading:9784332-Humans,
pubmed-meshheading:9784332-Immunohistochemistry,
pubmed-meshheading:9784332-Microcirculation,
pubmed-meshheading:9784332-Middle Aged,
pubmed-meshheading:9784332-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:9784332-Ovarian Neoplasms,
pubmed-meshheading:9784332-Survival Rate
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: an immunohistochemical and serological analysis.
|
|
pubmed:affiliation |
Service de Gynécologie-Obstétrique, Hôpital Bichat, Université Paris, 7 Denis Diderot, Paris, 75018, France.
|
|
pubmed:publicationType |
Journal Article
|
